NEU 1.52% $12.94 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-179

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,819 Posts.
    lightbulb Created with Sketch. 338


    An aquirer will likely have many other parts. So the exposure for Neurens assets would be highly diluted if a current shareholder invested in the aquirer.

    Thus it would`t be effective. IMO

    Best to get the maximum possible when/if TO occurs. Not good enough offer, send `em packing.

    It will really depend if there is more than 1 suitor.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$12.94
Change
-0.200(1.52%)
Mkt cap ! $1.653B
Open High Low Value Volume
$13.03 $13.06 $12.75 $7.500M 581.8K

Buyers (Bids)

No. Vol. Price($)
1 2300 $12.93
 

Sellers (Offers)

Price($) Vol. No.
$12.96 2086 1
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.